Radiolabeling Rhesus monkey CD34+ hematopoietic and mesenchymal stem cells with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for MicroPET imaging

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Noninvasive positron emission tomography (PET) provides a potential method for in vivo tracking of radiolabeled cells. The goal of this study was to assess the potential toxicity of 64Cu-pyruvaldehyde-bis(N4- methylthiosemicarbazone) (PTSM) on rhesus monkey CD34+ hematopoietic and mesenchymal stem cells in vitro in preparation for developing imaging protocols posttransplantation. CD34+ hematopoietic cells were radiolabeled with 0 to 40 μCi/mL 64Cu-PTSM and viability and colony formation were assessed. Rhesus monkey mesenchymal stem cells (rhMSCs) were placed in culture postradiolabeling for assessments of growth and differentiation toward adipogenic, osteogenic, and chondrogenic lineages. The results indicated that CD34+ cells radiolabeled with 20 μCi/mL and rhMSCs radiolabeled with 10 (μCi/mL 64Cu-PTSM did not result in adverse effects on growth or differentiation. Nonradioactive copper was also evaluated and showed that the presence of copper was not harmful to the cells. CD34+ cells and rhMSCs radiolabeled with the optimized concentrations of 20 and 10 (μCi/mL, respectively, were also assessed using the microPET scanner. Studies showed that a minimum of 2.50 × 10+ CD34 cells (1.1 pCi/cell) and 6.25 × 103 rhMSCs (4.4 pCi/cell) could be detected. These studies indicate that CD34+ hematopoietic cells and rhMSCs can be safely radiolabeled with 64Cu-PTSM without adverse cellular effects.

Original languageEnglish (US)
Pages (from-to)1-11
Number of pages11
JournalMolecular Imaging
Volume7
Issue number1
DOIs
StatePublished - Jan 2008

Fingerprint

Pyruvaldehyde
monkeys
stem cells
Hematopoietic Stem Cells
Stem cells
Macaca mulatta
Mesenchymal Stromal Cells
Imaging techniques
cells
Copper
Positron emission tomography
Cell Tracking
Cell culture
Toxicity
copper
Growth
Positron-Emission Tomography
viability
toxicity
scanners

ASJC Scopus subject areas

  • Engineering(all)
  • Radiology Nuclear Medicine and imaging
  • Biotechnology
  • Molecular Medicine
  • Biomedical Engineering
  • Condensed Matter Physics

Cite this

@article{d99252461d6d4823bbabe0e922f7973f,
title = "Radiolabeling Rhesus monkey CD34+ hematopoietic and mesenchymal stem cells with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for MicroPET imaging",
abstract = "Noninvasive positron emission tomography (PET) provides a potential method for in vivo tracking of radiolabeled cells. The goal of this study was to assess the potential toxicity of 64Cu-pyruvaldehyde-bis(N4- methylthiosemicarbazone) (PTSM) on rhesus monkey CD34+ hematopoietic and mesenchymal stem cells in vitro in preparation for developing imaging protocols posttransplantation. CD34+ hematopoietic cells were radiolabeled with 0 to 40 μCi/mL 64Cu-PTSM and viability and colony formation were assessed. Rhesus monkey mesenchymal stem cells (rhMSCs) were placed in culture postradiolabeling for assessments of growth and differentiation toward adipogenic, osteogenic, and chondrogenic lineages. The results indicated that CD34+ cells radiolabeled with 20 μCi/mL and rhMSCs radiolabeled with 10 (μCi/mL 64Cu-PTSM did not result in adverse effects on growth or differentiation. Nonradioactive copper was also evaluated and showed that the presence of copper was not harmful to the cells. CD34+ cells and rhMSCs radiolabeled with the optimized concentrations of 20 and 10 (μCi/mL, respectively, were also assessed using the microPET scanner. Studies showed that a minimum of 2.50 × 10+ CD34 cells (1.1 pCi/cell) and 6.25 × 103 rhMSCs (4.4 pCi/cell) could be detected. These studies indicate that CD34+ hematopoietic cells and rhMSCs can be safely radiolabeled with 64Cu-PTSM without adverse cellular effects.",
author = "Joanne Huang and Lee, {C. Chang I} and Sutcliffe, {Julie L.} and Cherry, {Simon R.} and Tarantal, {Alice F.}",
year = "2008",
month = "1",
doi = "10.2310/7290.2008.00001",
language = "English (US)",
volume = "7",
pages = "1--11",
journal = "Molecular Imaging",
issn = "1535-3508",
publisher = "Decker Publishing",
number = "1",

}

TY - JOUR

T1 - Radiolabeling Rhesus monkey CD34+ hematopoietic and mesenchymal stem cells with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for MicroPET imaging

AU - Huang, Joanne

AU - Lee, C. Chang I

AU - Sutcliffe, Julie L.

AU - Cherry, Simon R.

AU - Tarantal, Alice F.

PY - 2008/1

Y1 - 2008/1

N2 - Noninvasive positron emission tomography (PET) provides a potential method for in vivo tracking of radiolabeled cells. The goal of this study was to assess the potential toxicity of 64Cu-pyruvaldehyde-bis(N4- methylthiosemicarbazone) (PTSM) on rhesus monkey CD34+ hematopoietic and mesenchymal stem cells in vitro in preparation for developing imaging protocols posttransplantation. CD34+ hematopoietic cells were radiolabeled with 0 to 40 μCi/mL 64Cu-PTSM and viability and colony formation were assessed. Rhesus monkey mesenchymal stem cells (rhMSCs) were placed in culture postradiolabeling for assessments of growth and differentiation toward adipogenic, osteogenic, and chondrogenic lineages. The results indicated that CD34+ cells radiolabeled with 20 μCi/mL and rhMSCs radiolabeled with 10 (μCi/mL 64Cu-PTSM did not result in adverse effects on growth or differentiation. Nonradioactive copper was also evaluated and showed that the presence of copper was not harmful to the cells. CD34+ cells and rhMSCs radiolabeled with the optimized concentrations of 20 and 10 (μCi/mL, respectively, were also assessed using the microPET scanner. Studies showed that a minimum of 2.50 × 10+ CD34 cells (1.1 pCi/cell) and 6.25 × 103 rhMSCs (4.4 pCi/cell) could be detected. These studies indicate that CD34+ hematopoietic cells and rhMSCs can be safely radiolabeled with 64Cu-PTSM without adverse cellular effects.

AB - Noninvasive positron emission tomography (PET) provides a potential method for in vivo tracking of radiolabeled cells. The goal of this study was to assess the potential toxicity of 64Cu-pyruvaldehyde-bis(N4- methylthiosemicarbazone) (PTSM) on rhesus monkey CD34+ hematopoietic and mesenchymal stem cells in vitro in preparation for developing imaging protocols posttransplantation. CD34+ hematopoietic cells were radiolabeled with 0 to 40 μCi/mL 64Cu-PTSM and viability and colony formation were assessed. Rhesus monkey mesenchymal stem cells (rhMSCs) were placed in culture postradiolabeling for assessments of growth and differentiation toward adipogenic, osteogenic, and chondrogenic lineages. The results indicated that CD34+ cells radiolabeled with 20 μCi/mL and rhMSCs radiolabeled with 10 (μCi/mL 64Cu-PTSM did not result in adverse effects on growth or differentiation. Nonradioactive copper was also evaluated and showed that the presence of copper was not harmful to the cells. CD34+ cells and rhMSCs radiolabeled with the optimized concentrations of 20 and 10 (μCi/mL, respectively, were also assessed using the microPET scanner. Studies showed that a minimum of 2.50 × 10+ CD34 cells (1.1 pCi/cell) and 6.25 × 103 rhMSCs (4.4 pCi/cell) could be detected. These studies indicate that CD34+ hematopoietic cells and rhMSCs can be safely radiolabeled with 64Cu-PTSM without adverse cellular effects.

UR - http://www.scopus.com/inward/record.url?scp=44949240440&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44949240440&partnerID=8YFLogxK

U2 - 10.2310/7290.2008.00001

DO - 10.2310/7290.2008.00001

M3 - Article

C2 - 18384718

AN - SCOPUS:44949240440

VL - 7

SP - 1

EP - 11

JO - Molecular Imaging

JF - Molecular Imaging

SN - 1535-3508

IS - 1

ER -